There are 2137 resources available
517P - Early stage squamous cell carcinoma of the anal canal: Results of curative-intent therapy in a multicenter retrospective study
Presenter: Iara Lustosa
Session: E-Poster Display
Resources:
Abstract
518P - Treatment outcome and prognostic factors after chemoradiotherapy for anal cancer
Presenter: Kathinka Slørdahl
Session: E-Poster Display
Resources:
Abstract
519P - Patterns of care and outcomes in carcinoma of unknown primary: A SEER-Medicare study
Presenter: Linda Mileshkin
Session: E-Poster Display
Resources:
Abstract
520TiP - A multicenter study to evaluate the impact of circulating tumor DNA guided therapy (BESPOKE) in patients with stage II and III colorectal cancer
Presenter: Pashtoon Kasi
Session: E-Poster Display
Resources:
Abstract
521TiP - Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer according the trials within cohorts design: The MEDOCC-CrEATE trial
Presenter: Suzanna Schraa
Session: E-Poster Display
Resources:
Abstract
522TiP - PRODIGE 71 - BEVAMAINT: A randomized phase III study comparing maintenance treatment with fluoropyrimidine + bevacizumab versus fluoropyrimidine after induction chemotherapy for a metastatic colorectal cancer
Presenter: Thomas Aparicio
Session: E-Poster Display
Resources:
Abstract
523TiP - MOUNTAINEER: Open-label, phase II study of tucatinib combined with trastuzumab for HER2-positive metastatic colorectal cancer
Presenter: John Strickler
Session: E-Poster Display
Resources:
Abstract
538P - Vemurafenib in non-melanoma V600 and non-V600 BRAF mutated cancers: Results of the AcSé basket trial
Presenter: Pascale Tomasini
Session: E-Poster Display
Resources:
Abstract
539P - Patient-reported outcomes (PROs) from patients (Pts) with NTRK fusion-positive (NTRK-fp) solid tumours receiving entrectinib in the global phase II STARTRK-2 study
Presenter: Anthony Conley
Session: E-Poster Display
Resources:
Abstract
540P - Entrectinib in patients with <italic>ROS1</italic> fusion-positive non-small cell lung cancer (NSCLC) or <italic>NTRK</italic> fusion-positive solid tumours: Analysis of response by line of therapy
Presenter: Stephen Liu
Session: E-Poster Display
Resources:
Abstract